Literature DB >> 17995942

Visceral adipose tissue area is an independent risk factor for hepatic steatosis.

Bum J Park1, Yoon J Kim, Dong H Kim, Won Kim, Yong J Jung, Jung H Yoon, Chung Y Kim, Young M Cho, Se H Kim, Kyoung B Lee, Ja J Jang, Hyo S Lee.   

Abstract

BACKGROUND AND AIM: Recent data indicate that hepatic steatosis is associated with insulin resistance, dyslipidemia and obesity (especially central body fat distribution). There have been few studies on the correlation between biopsy-proven hepatic steatosis and the above factors in a disease-free population. The aim of the present study was to evaluate the relation between hepatic steatosis assessed by biopsy and clinical characteristics including regional fat distribution measured by computed tomography (CT) in living liver donors.
METHODS: Laboratory data, liver/spleen Hounsfield ratio (L/S ratio), regional fat distribution by CT and liver status by biopsy were evaluated retrospectively in a total of 177 living liver donors without a history of alcohol intake.
RESULTS: The unpaired t-test showed that age, triglycerides (TG), high density lipoprotein, total cholesterol, alanine aminotransferase, body mass index, L/S ratio, visceral adipose tissue area (VAT) and subcutaneous adipose tissue area (SAT) were associated with hepatic steatosis. In the multiple logistic regression analysis, VAT (odds ratio 1.031, 95% CI 1.013-1.048, P < 0.01) and TG (odds ratio 1.012, 95% CI 1.004-1.020, P < 0.01) were independent risk factors of hepatic steatosis. Subgroup analysis also showed that VAT was an independent risk factor in men (odds ratio 1.022, 95% CI 1.003-1.041, P < 0.05) and women (odds ratio 1.086, 95% CI 1.010-1.168, P < 0.05).
CONCLUSION: Our results suggest that visceral abdominal adiposity is correlated with hepatic steatosis in healthy living liver donors.

Entities:  

Mesh:

Year:  2007        PMID: 17995942     DOI: 10.1111/j.1440-1746.2007.05212.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  40 in total

1.  Correlations between quantitative fat-water magnetic resonance imaging and computed tomography in human subcutaneous white adipose tissue.

Authors:  Aliya Gifford; Ronald C Walker; Theodore F Towse; E Brian Welch
Journal:  J Med Imaging (Bellingham)       Date:  2015-12-18

2.  Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the Coronary Artery Risk Development in Young Adults Study.

Authors:  Lisa B VanWagner; Hongyan Ning; Cora E Lewis; Christina M Shay; John Wilkins; J Jeffrey Carr; James G Terry; Donald M Lloyd-Jones; David R Jacobs; Mercedes R Carnethon
Journal:  Atherosclerosis       Date:  2014-06-10       Impact factor: 5.162

3.  Genetic and hormonal control of hepatic steatosis in female and male mice.

Authors:  Frode Norheim; Simon T Hui; Emre Kulahcioglu; Margarete Mehrabian; Rita M Cantor; Calvin Pan; Brian W Parks; Aldons J Lusis
Journal:  J Lipid Res       Date:  2016-11-03       Impact factor: 5.922

4.  Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease.

Authors:  Jaividhya Dasarathy; Pranav Periyalwar; Sanath Allampati; Vikram Bhinder; Carol Hawkins; Patricia Brandt; Amer Khiyami; Arthur J McCullough; Srinivasan Dasarathy
Journal:  Liver Int       Date:  2013-10-01       Impact factor: 5.828

5.  Associated factors for a hyperechogenic pancreas on endoscopic ultrasound.

Authors:  Cheol Woong Choi; Gwang Ha Kim; Dae Hwan Kang; Hyung Wook Kim; Dong Uk Kim; Jeong Heo; Geun Am Song; Do Youn Park; Suk Kim
Journal:  World J Gastroenterol       Date:  2010-09-14       Impact factor: 5.742

Review 6.  Quantification of hepatic and visceral fat by CT and MR imaging: relevance to the obesity epidemic, metabolic syndrome and NAFLD.

Authors:  Peter M Graffy; Perry J Pickhardt
Journal:  Br J Radiol       Date:  2016-03-09       Impact factor: 3.039

Review 7.  Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.

Authors:  Donald B Jump; Kelli A Lytle; Christopher M Depner; Sasmita Tripathy
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

8.  Preoperative 4-week supplementation with omega-3 polyunsaturated fatty acids reduces liver volume and facilitates bariatric surgery in morbidly obese patients.

Authors:  Antonio Iannelli; Francesco Martini; Anne Sophie Schneck; Bijan Ghavami; Guillaume Baudin; Rodolphe Anty; Jean Gugenheim
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

9.  Visceral, subcutaneous abdominal adiposity and liver fat content distribution in normal glucose tolerance, impaired fasting glucose and/or impaired glucose tolerance.

Authors:  A L Borel; J A Nazare; J Smith; P Aschner; P Barter; L Van Gaal; C Eng Tan; H U Wittchen; Y Matsuzawa; T Kadowaki; R Ross; C Brulle-Wohlhueter; N Alméras; S M Haffner; B Balkau; J P Després
Journal:  Int J Obes (Lond)       Date:  2014-09-02       Impact factor: 5.095

10.  Emodin attenuates systemic and liver inflammation in hyperlipidemic mice administrated with lipopolysaccharides.

Authors:  Xuemei Jia; Stephen Iwanowycz; Junfeng Wang; Fatma Saaoud; Fang Yu; Yuzhen Wang; Jun Hu; Saurabh Chatterjee; Qian Wang; Daping Fan
Journal:  Exp Biol Med (Maywood)       Date:  2014-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.